Siolta Therapeutics

Siolta Therapeutics

The human microbiome has emerged as a key driver of immune dysfunction. At Siolta Therapeutics, we leverage multi-scale next-generation microbiome analyses to develop and test microbial-based therapeutics for the treatment and prevention of inflammatory diseases.

Area of focus: 
Other
Commencement date: 
03/06/2017

Share